GQX — Antiserum, Cf, Varicella-Zoster Class II

FDA Device Classification

FDA product code GQX covers "Antiserum, Cf, Varicella-Zoster", a Class II medical device regulated under 21 CFR 866.3900. Submissions are reviewed by the Microbiology panel. At least 11 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
GQX
Device Class
Class II
Regulation Number
866.3900
Submission Type
510(k)
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K951799Light DiagnosticsVARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAYMar 20, 1996
K911301Gull LaboratoriesVZV IGM TESTJul 17, 1991
K883427Electro-NucleonicsVIRGO(R) VZV-IGG ELISAMar 10, 1989
K875358Gull LaboratoriesVZV TESTMar 31, 1988
K863317Behring DiagnosticsENZYGNOST ANTI-VZV IGG TESTApr 22, 1987
K853540Idt, A Division Of Whittaker M.A. BioproductsFIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGYFeb 4, 1986
K852930Microbix BiosystemsVARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRONov 12, 1985
K842096Great Lakes BioscienceGLB VARICELLA-ZOSTER VIRUS FLUORESCENTJan 7, 1985
K841526Ortho Diagnostic SystemsORTHO VARICELLA-ZOSTER VIRUS IDENT.Jun 25, 1984
K770810Flow LaboratoriesVARICELLA-ZOSTER FA LABELED PRESERUMMay 20, 1977
K770806Flow LaboratoriesVARICELLA-ZOSTER FA LABELLED (8-321 RF)May 20, 1977

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.